Skip to main content
. 2016 Sep 7;22(33):7587–7594. doi: 10.3748/wjg.v22.i33.7587

Table 2.

Prevalence of H. pylori resistance to clarithromycin and fluoroquinolones in each region

Northern (n = 36) North-Eastern (n = 138) Central-Western (n = 26) South-Eastern (n = 217) Southern (n = 73) P value Total (n = 490)
Clarithromycin resistance 16.6% 14.5% 19.2% 17.5% 19.1% 0.55 16.9% (95%CI: 13.7%-20.6%)
Fluoroquinolones resistance 2.7% 13.7% 15.4% 13.8% 16.4% 0.06 13.5% (95%CI: 10.6%-16.8%)